Stem cell therapy could treat Parkinson's

A novel non-embyronic stem cell therapy is being studied to replace damaged dopaminergic brain cells in Parkinson's patients with their own cells in the hopes of restoring normal movement.

The Parkinson's Association of San Diego, Scripps Research Institute and Scripps Clinic have mounted an effort to promote the treatment, which is based on the harvesting of stem cells from patients' skin. A formal application for the treatment will reportedly be filed with the FDA this month.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.